These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 532636)

  • 21. [The anti-arrhythmia properties of thymogen].
    Reznikov KM; Vinokurova OV; Alabovskiĭ VV; Vinokurov AA
    Eksp Klin Farmakol; 1994; 57(6):31-3. PubMed ID: 7756955
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Antiarrhythmic properties of the anticonvulsant drug benzonal].
    Saratikov AS; Fateeva SN; Forshkova VK
    Farmakol Toksikol; 1987; 50(6):42-4. PubMed ID: 3436422
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiarrhythmic properties of Craviten (M-71) in cats and rabbits.
    Chodera A; Banaszkiewicz W; Glinka B
    Pol J Pharmacol Pharm; 1980; 32(6):833-40. PubMed ID: 7243680
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparative characteristics of the antiarrhythmic activity of lidocaine, trimecaine and pyromecaine].
    Orlov VM; Ivashchuk AG; Iartsev SS; Meshcheriakova NK; Tkhu FT
    Sov Med; 1984; (3):82-4. PubMed ID: 6719244
    [No Abstract]   [Full Text] [Related]  

  • 25. [Some aspects of the antiarrhythmic effect of glialin].
    Khisatmutdinova RIu; Baschenko NZh; Zarudiĭ FS; Gabdrakhmanova SF; Makara NS; Sapozhnikova TA
    Eksp Klin Farmakol; 2006; 69(3):26-8. PubMed ID: 16878494
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of a water-soluble fraction of radix Aconiti Lateralis Preparata on experimental arrhythmia].
    Shao L; Zhou YP
    Zhong Yao Tong Bao; 1988 Jun; 13(6):42-4, 64. PubMed ID: 3203442
    [No Abstract]   [Full Text] [Related]  

  • 27. [Antiarrhythmic effects of iodium-heterocycle compounds].
    Cao W; Zhao DH; Sheng BH; Chen SY
    Yao Xue Xue Bao; 1986 Mar; 21(3):161-4. PubMed ID: 3788579
    [No Abstract]   [Full Text] [Related]  

  • 28. [Cardiovascular effect of a new antiarrhythmic drug--changrolin (author's transl)].
    Chen WZ; Dong YL; Ding GS
    Yao Xue Xue Bao; 1979 Dec; 14(12):710-4. PubMed ID: 554432
    [No Abstract]   [Full Text] [Related]  

  • 29. [Comparison of antiarrhythmic effects of IHC-72 (an iodonium-72), lidocaine and verapamil].
    Ji GJ; Zhao DH; Liu DQ; Sheng BH
    Yao Xue Xue Bao; 1992; 27(6):407-11. PubMed ID: 1442066
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Anti-arrhythmia properties of pyromecaine].
    Zakusov VV; Prianishnikova NT; Cherniakova IV; Samvelian VM; L'vov MV
    Farmakol Toksikol; 1983; 46(5):32-7. PubMed ID: 6628657
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The anti-arrhythmia activity of new dicyclohexylamide derivatives of N-substituted alpha-aminocarboxylic acids].
    Berdiaev SU; Paliani-Katsitadze NSh; Turilova AI; Kaverina NV; Likhosherstov AM; Lebedeva AS; Ogurtsov VA
    Eksp Klin Farmakol; 1999; 62(4):26-9. PubMed ID: 10513331
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The effect of dalargin on the course of experimental cardiac arrhythmias].
    Grekova TI; Reznikov KM; Vinokurova OV; Kireeva AA; Taratinova TI; Nikolaevskiĭ VA; Shchetinkina NA
    Eksp Klin Farmakol; 1994; 57(2):24-6. PubMed ID: 8205043
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacological investigation of a new anti-arrhythmic agent, GYKI-23 107.
    Varró A; Rabloczky G; Jaszlits L; Kürthy M; Zubovics Z; Toldy L
    Drugs Exp Clin Res; 1987; 13(1):21-8. PubMed ID: 3595441
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The relationship between the chemical structure and anti-arrhythmia action of a number of omega-aminoacyl-3-carbalcoxyaminodibenzazepines].
    Gritsenko AN; Lyskovtsev VV; Senova ZP; Skoldinov AP; Stark A; Wunderlich G; Poppe H; Barch R
    Farmakol Toksikol; 1990; 53(3):30-2. PubMed ID: 2387375
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Action of anti-arrhythmia agents in ischemia and hyperoxia].
    Kedrov SI; Reznikov KM; Leonov AN
    Farmakol Toksikol; 1988; 51(1):41-4. PubMed ID: 3360106
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Example of dose finding in practice. Pharmacology of an antiarrhythmic agent (author's transl)].
    Oberdorf A; Raschack M
    Arzneimittelforschung; 1977 Feb; 27(2A):281-3. PubMed ID: 577176
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Plasma drug concentration and cardiac function in arrhythmic patients during continuous drip of changrolin].
    Xu JM; Yin XL; Chen YM; Qi HM; Li CF; Shen LY; Chen WZ; Wang CG
    Zhongguo Yao Li Xue Bao; 1987 May; 8(3):227-31. PubMed ID: 2959017
    [No Abstract]   [Full Text] [Related]  

  • 38. [Comparing the actions of the three flavone ingredients in choerospondias axillaris on arrhythmias induced by aconitine].
    Wang FH; Yang YM; Xu JH; Qin JM; Ying K; Zhang CZ; Song YT; Yu TF
    Zhongguo Zhong Yao Za Zhi; 2005 Jul; 30(14):1096-8. PubMed ID: 16161447
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiarrhythmic effects of LR-A/113 a new calcium antagonistic drug.
    Stella L; de Novellis V; Vacca C; Guarino A; Cantoni V; Fici F; Rossi F
    Res Commun Mol Pathol Pharmacol; 1996 Aug; 93(2):235-48. PubMed ID: 8884994
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiarrhythmic activity of a membrane-protecting agent Sal'magin in rats with aconitine-induced arrhythmias.
    Klekot AA
    Bull Exp Biol Med; 2006 Aug; 142(2):209-11. PubMed ID: 17369941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.